mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
1 |